Abstract
Diabetes mellitus has reached epidemic proportions worldwide. Patients with diabetes are at increased risk for acute coronary syndromes, and these syndromes lead to frequent morbidity and cardiovascular mortality. Emerging adjunctive pharmacological strategies coupled with the drug-eluting stent platform have resulted in improved adverse event rates for this high-risk group. This review will concentrate on the historical data associated with acute coronary syndromes in diabetes mellitus, focusing on revascularisation, drug-eluting stents and antiplatelet therapies.
Original language | English (US) |
---|---|
Pages (from-to) | 128-135 |
Number of pages | 8 |
Journal | Diabetes and Vascular Disease Research |
Volume | 2 |
Issue number | 3 |
DOIs | |
State | Published - Oct 2005 |
Keywords
- Acute coronary syndromes
- Antiplatelet therapy
- Diabetes
- Drug-eluting stents
- Percutaneous coronary intervention
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Cardiology and Cardiovascular Medicine